Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-033510
Filing Date
2025-03-05
Accepted
2025-03-05 16:03:44
Documents
94
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fate-20241231.htm   iXBRL 10-K 3560369
2 EX-10.5 fate-ex10_5.htm EX-10.5 20949
3 EX-10.41 fate-ex10_41.htm EX-10.41 125584
4 EX-19.1 fate-ex19_1.htm EX-19.1 136441
5 EX-23.1 fate-ex23_1.htm EX-23.1 6038
6 EX-31.1 fate-ex31_1.htm EX-31.1 12569
7 EX-32.1 fate-ex32_1.htm EX-32.1 8124
8 GRAPHIC img143810944_0.jpg GRAPHIC 166452
9 GRAPHIC img143810944_1.jpg GRAPHIC 327111
10 GRAPHIC img143810944_2.jpg GRAPHIC 138273
11 GRAPHIC img143810944_3.jpg GRAPHIC 61402
12 GRAPHIC img143810944_4.jpg GRAPHIC 92470
13 GRAPHIC img143810944_5.jpg GRAPHIC 198985
14 GRAPHIC img143810944_6.jpg GRAPHIC 181411
15 GRAPHIC img143810944_7.jpg GRAPHIC 114168
16 GRAPHIC img143810944_8.jpg GRAPHIC 73696
  Complete submission text file 0000950170-25-033510.txt   17521572

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fate-20241231.xsd EX-101.SCH 1804731
97 EXTRACTED XBRL INSTANCE DOCUMENT fate-20241231_htm.xml XML 2558155
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

EIN.: 651311552 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36076 | Film No.: 25710824
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)